Rani Therapeutics Holdings Inc
(NAS:RANI)
$
2.51
0.03 (1.21%)
Market Cap: 81.55 Mil
Enterprise Value: 84.60 Mil
PE Ratio: 0
PB Ratio: 22.82
GF Score: 32/100 Rani Therapeutics Holdings Inc at Cantor Fitzgerald Global Healthcare Conference Transcript
Sep 28, 2023 / 12:35PM GMT
Release Date Price:
$2.65
(-5.36%)
Olivia Brayer
Cantor Fitzgerald LP - Analyst
Okay, great. Hey, good morning, everyone. Welcome to day three and final day, unfortunately, of our global Cantor Healthcare Conference. It's been a lot of fun having everyone in person.
My name's Olivia Brayer. I'm a senior biotech analyst here at Cantor, and really excited to have our guest speaker with us today from Rani Therapeutics. We have Talat Imran who's CEO of the company. Talat, thanks so much for joining us.
Talat Imran
Rani Therapeutics Holdings, Inc. - CEO
Olivia, thank you for having us here and allowing us to now have a fireside chat.
Olivia Brayer
Cantor Fitzgerald LP - Analyst
Yeah, we were going to do slides. But personally, I find slides a little bit more boring.
Talat Imran
Rani Therapeutics Holdings, Inc. - CEO
I find them super boring.
Olivia Brayer
Cantor Fitzgerald LP - Analyst
We'll put Talat on the spot today. It'll be good.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot